MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells

Cell Proliferation

Volumn 45, Issue 1, 2012, Pages 32-38

  Ohdaira, H ^a   Sekiguchi, M ^a   Miyata, K ^a   Yoshida, K ^a  

^a MEIJI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MICRORNA 494; RNA; SOMATOMEDIN B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CELL FUNCTION; CELL PROLIFERATION; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME REPRESSION; LUNG CANCER; NUCLEOTIDE SEQUENCE; RNA BINDING; SENESCENCE; UPREGULATION;

APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LUNG NEOPLASMS; MICRORNAS; RNA, NEOPLASM; RNA-BINDING PROTEINS; TRANSFORMATION, GENETIC; TUMOR STEM CELL ASSAY;

EID: 84655169614     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00798.x     Document Type: Article

References (16)

1. Kawaji H, Hayashizaki Y (2008) Exploration of small RNAs. PLoS Genet. 4, e22.
2. Zhang C (2009) Novel functions for small RNA molecules. Curr. Opin. Mol. Ther. 11, 641-651.
3. Lai EC (2002) Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 30, 363-364.
4. Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302, 1-12.
5. Ohdaira H, Sasaki T, Yoshida K (2010) A subset of microRNAs potentially acts as a convergent hub for upstream transcription factors in cancer cells. Oncol. Rep. 24, 1371-1381.
6. Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J et al. (2009) Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv. Syst. 1, 13-20.
7. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC (1999) A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol. Cell. Biol. 19, 1262-1270.
8. Ioannidis P, Mahaira L, Papadopoulou A, Teixeira MR, Heim S, Andersen JA et al. (2003) CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression. Anticancer Res. 23, 2179-2183.
9. Boyerinas B, Park SM, Shomron N, Hedegaard MM, Vinther J, Andersen JS et al. (2008) Identification of let-7-regulated oncofetal genes. Cancer Res. 68, 2587-2591.
10. Liu L, Jiang Y, Zhang H, Greenlee AR, Han Z (2010) Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo(a)pyrene-trans-7, 8-dihydrodiol-9, 10-epoxide. Life Sci. 86, 192-198.
11. Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840.
12. Ioannidis P, Mahaira LG, Perez SA, Gritzapis AD, Sotiropoulou PA, Kavalakis GJ et al. (2005) CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells. J. Biol. Chem. 280, 20086-20093.
13. Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J et al. (2010) MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 122, 1308-1318.
14. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al. (2005) Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500.
15. Elcheva I, Tarapore RS, Bhatia N, Spiegelman VS (2008) Overexpression of mRNA-binding protein CRD-BP in malignant melanomas. Oncogene 27, 5069-5074.
16. Polychronakos C, Giannoukakis N, Deal CL (1995) Imprinting of IGF2, insulin-dependent diabetes, immune function, and apoptosis: a hypothesis. Dev. Genet. 17, 253-262.